![](/img/cover-not-exists.png)
Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based onEGFRMutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
Schremser, Katharina, Rogowski, Wolf H., Adler-Reichel, Sigrid, Tufman, Amanda L. H., Huber, Rudolf M., Stollenwerk, BjörnVolume:
33
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-015-0305-8
Date:
November, 2015
File:
PDF, 862 KB
english, 2015